{
    "Trade/Device Name(s)": [
        "eSensor\u00ae Warfarin Sensitivity Saliva Test",
        "eSensor\u00ae XT-8 Instrument"
    ],
    "Submitter Information": "Clinical Micro Sensor dba GenMark",
    "510(k) Number": "K110786",
    "Predicate Device Reference 510(k) Number(s)": [
        "K073720"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "ODW",
        "ODV",
        "NSU"
    ],
    "Summary Letter Date": "October 24, 2011",
    "Summary Letter Received Date": "October 27, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.7280",
        "21CFR862.2570",
        "21CFR862.3360"
    ],
    "Regulation Name(s)": [
        "Drug Metabolizing Enzyme Genotyping System",
        "Instrument for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "hematology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "CYP450 2C9 *2 allele",
        "CYP450 2C9 *3 allele",
        "VKORC1 -1639G>A polymorphism"
    ],
    "Specimen Type(s)": [
        "Saliva"
    ],
    "Specimen Container(s)": [
        "Oragene\u00ae Dx Device"
    ],
    "Instrument(s)/Platform(s)": [
        "eSensor\u00ae XT-8 Instrument",
        "eSensor\u00ae XT-8 Cartridge"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex microarray-based genotyping",
        "Competitive DNA hybridization",
        "Polymerase chain reaction (PCR)",
        "Exonuclease digestion",
        "Electrochemical detection (ACV)"
    ],
    "Methodologies": [
        "Genotyping",
        "Sandwich hybridization assay",
        "Microarray",
        "PCR amplification"
    ],
    "Submission Type(s)": [
        "Test",
        "Kit",
        "Instrument",
        "System",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for eSensor Warfarin Sensitivity Saliva Test for genotyping CYP2C9 and VKORC1 alleles using saliva and XT-8 system.",
    "Indications for Use Summary": "In vitro diagnostic for detecting and genotyping CYP2C9 *2 and *3 alleles and VKORC1 -1639G>A polymorphism from human saliva DNA to aid identification of patients at risk for increased warfarin sensitivity.",
    "fda_folder": "Clinical Chemistry"
}